NT 10-K 1 hyex_nt10k.htm HEALTHY EXTRACTS INC. 12B-25 Renewable Innovations 10-Q Late Notice 2.28.23 (02127246).DOCX

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

SEC File No: 000-5572

 

Washington, D.C. 20549

CUSIP No:  42227D 20 9

 

FORM 12b-25

 

NOTIFICATION OF LATE FILING

 

(Check One):

x Form 10-K

¨ Form 20-F

¨ Form 11-K

¨ Form 10-Q

¨ Form 10-D

 

¨ Form N-CEN

¨ Form N-CSR

 

 

 

 

 

For Period Ended:

December 31, 2024

 

 

 

¨

 

Transition report on Form 10-K

¨

 

Transition report on Form 20-F

¨

 

Transition report on Form 11-K

¨

 

Transition report on Form 10-Q

¨

 

Transition report on Form N-SAR

 

For the Transition Period Ended:   

 

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
__________________________________________________________________________

 

PART 1 -- REGISTRANT INFORMATION

 

Healthy Extracts Inc.

Full Name of Registrant

 

 

Former Name if Applicable

 

7375 Commercial Way, Suite 125

Address of Principal Executive Office (Street and Number)

 

Henderson, NV 89011

City, State and Zip Code

 

PART II -- RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)


 

 

x

 

(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or a portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

 

(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III -- NARRATIVE

 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

On March 31, 2025, the Registrant was notified by their independent auditor that since the implementation of QC1000 they are running behind. The Registrant intends to file the subject Annual Report on Form 10-K on or before the fifthteenth calendar day following the prescribed due date.

 

PART IV-- OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification

 

Kevin “Duke” Pitts

(702)

463-1004

(Name)

(Area Code)

(Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).  

x Yes   ¨ No  

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

¨ Yes   x No

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 

 

Healthy Extracts Inc.

 

 

(Name of Registrant as Specified in Charter)

 

 

 

 

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date

April 1, 2025

 

By

/s/ Kevin “Duke” Pitts

 

 

 

 

Kevin “Duke” Pitts

 

 

 

 

President